Psychiatry and Neurology, Epilepsy · Columbus, OH
NPI
1548474406
Since 2007
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3555 Olentangy River Rd Ste 2002
Columbus, OH, 43214
Phone (614) 533-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
499 services
Medicare patients, 2024
230
Average age 66
Drug cost, 2024
$1.4M
2,617 prescriptions
Company payments, 2025
$7,307
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emily T Klatte was code 95720 (neurologic), 190 times for 98 patients. In total Emily T Klatte billed 499 services in 23 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 190 | 98 | $162.11 | $31K |
| 99214 Office E&M - Established | Office | 93 | 64 | $84.22 | $7,833 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 52 | 42 | $12.34 | $642 |
| 95816 Neurologic | Facility | 45 | 45 | $44.38 | $1,997 |
| 99215 Office E&M - Established | Office | 33 | 24 | $102.82 | $3,393 |
| 95718 Neurologic | Facility | 24 | 23 | $105.73 | $2,538 |
By year: 2022 $52K for 476 services; 2023 $45K for 412 services; 2024 $52K for 499 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emily T Klatte prescribed most often to Medicare patients was Levetiracetam, with 265 prescriptions and refills. In total Emily T Klatte wrote 2,617 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 265 | 432 | 47 | $10K |
| Lamotrigine Generic | 156 | 281 | 36 | $2,529 |
| Lacosamide Generic | 156 | 240 | 33 | $33K |
| Clobazam Generic | 138 | 158 | 22 | $20K |
| Topiramate Generic | 133 | 231 | 24 | $3,617 |
| Clonazepam Generic | 114 | 120 | 19 | $1,250 |
| Gabapentin Generic | 92 | 119 | 19 | $2,202 |
| Vimpat Lacosamide | 86 | 98 | Under 11 | $95K |
| Zonisamide Generic | 83 | 120 | 12 | $1,819 |
| Levetiracetam Er Levetiracetam | 78 | 178 | 24 | $5,767 |
| Xcopri Cenobamate | 64 | 68 | Under 11 | $100K |
| Oxcarbazepine Generic | 59 | 125 | 14 | $8,225 |
| Keppra Xr Levetiracetam | 56 | 68 | Under 11 | $82K |
| Divalproex Sodium Generic | 52 | 89 | 12 | $1,562 |
| Lamotrigine Er Lamotrigine | 52 | 70 | Under 11 | $17K |
Brand drugs: 504 claims; generic drugs: 2,061 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emily T Klatte $7,307 ($7,307 in general payments such as food, travel and fees) from 5 companies. The largest payer was Neurelis, Inc. with $6,857.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.